Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from PR Newswire

19:46 EDT 23rd June 2018 | BioPortfolio

Here are the most relevant search results for "PR Newswire" found in our extensive news archives from over 250 global news sources.

More Information about PR Newswire on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about PR Newswire for you to read. Along with our medical data and news we also list PR Newswire Clinical Trials, which are updated daily. BioPortfolio also has a large database of PR Newswire Companies for you to search.

Showing News Articles 1–25 of 228 from PR Newswire

Friday 22nd June 2018

APAC Biotech and Diakonos Sign Technology Transfer and Licensing Agreement to Bring New Immunotherapy Technology to India

HOUSTON, June 22, 2018 /PRNewswire/ -- India-Based APAC Biotech and US-Based Diakonos Research sign a first-of-its-kind technology transfer and licensing agreement to bring new immunotherapy technology to India as an advancement of immuno-oncology therapeutics for solid tumors. This new path breaking technology effectively targets and activates the t

PharmaEngine Announces Positive Topline Results from Global Pivotal Trial of PEP503 (NBTXR3) in Soft Tissue Sarcoma

TAIPEI, Taiwan, June 22, 2018 /PRNewswire/ -- PharmaEngine Inc. (TWO: 4162) and its corporate partner, Nanobiotix S.A. (Euronext: NANO) announced today that PEP503 (NBTXR3) in combination with radiotherapy met the primary endpoint of pathological Complete Response Rate (pCRR) as compared to radiotherapy alone in a global pivotal phase II/III trial in patients with locally advanced soft tissue sarc...

Thursday 21st June 2018

GNTbm announces licensing of exclusive sales/marketing rights of anticancer drug Chidamide to Taiwan Specialty Pharma Corp. (TSPC)

TAIPEI, Taiwan, June 22, 2018 /PRNewswire/ -- GNT Biotech & Medicals Co., Ltd. (GNTbm, TPEx Emerging: 7427) announced that it has awarded exclusive sales and marketing rights in Taiwan of anticancer drug Chidamide to pharmaceutical distribution company Taiwan Specialty Pharma Corp. (TSPC) for two indications; hormone receptor-positive, HER-2 negative late stage breast cancer in post-menopausal...

Patient Safety Offers Lucrative Prospects for Innovative Solutions Providers, says Frost and Sullivan

SINGAPORE, June 21, 2018 /PRNewswire/ -- Adverse patient safety events in the US and Western European healthcare systems impose an estimated cost burden of US$ 317.93 billion in 2016 and is estimated to increase at a CAGR of 3.2% reaching US$ 383.7 billion in 2022. The rising incidences of adverse patient safety events push the demand for innovative solutions in healthcare industry as it affects m...

Prosten Health Holdings Limited officially renamed as "China Brilliant Global Limited"

HONG KONG, June 21, 2018 /PRNewswire/ -- Prosten Health Holdings Limited ("the Company"; Stock code: 08026) is pleased to announce the Company has officially renamed as "China Brilliant Global Limited" (referred to as "China Brilliant") with effect from 20 June 2018. China Brilliant has been striving for diversified development. Looking ahead, the Company will furth...

JCI-CRHG Academy of Hospital Management Named Exclusive Provider of JCI Advisory Services in the People's Republic of China

Academy to Provide Accreditation Technical Assistance, Preparation, Resources and Training OAK BROOK, Illinois, June 21, 2018 /PRNewswire/ -- Joint Commission International (JCI) and China Resources Healthcare Group Ltd. (CRHG) have named the JCI-CRHG Academy of Hospital Management, a joint venture of the two organizations, as the exclusive provider for JCI advisory service...

Wednesday 20th June 2018

Frost & Sullivan 2018 Award for Innovation in Artificial Intelligence for Aging Research and Drug Development

TAIPEI, Taiwan, June 20, 2018 /PRNewswire/ -- Rockville, MD, June 20, 2018, Insilico Medicine has been awarded the prestigious 2018 North American Technology Innovation Award from Frost & Sullivan for its pioneering work in Artificial Intelligence for Aging Research and Drug Development. The accolade was awarded in recognition of Insilico Medicine's "visionary capabilities in understandin...

Manulife Hong Kong launches ManuDelight Annuity Plan Simple, flexible retirement plan offers extra income protection

HONG KONG, June 20, 2018 /PRNewswire/ -- Manulife Hong Kong has launched ManuDelight Annuity Plan, an innovative solution for young and middle-aged people who want guaranteed retirement income in the future but also flexibility and extra income protection in case their circumstances change.

CStone enrolls first patient in Phase I study for MEK inhibitor CS3006 in Australia

SUZHOU, China, June 20, 2018 /PRNewswire/ -- CStone Pharmaceuticals (CStone) today announced the initiation of a Phase I clinical trial in Australia for CS3006, a highly selective, proprietary small molecule inhibitor of mitogen-activated protein kinase kinase (MEK). The first patient enrolled in the study has been dosed at the Linear Clinical Research Center in Australia. "MEK inhibition r...

Medtec China 2018 Concurrent Conference content first released

SHANGHAI, June 20, 2018 /PRNewswire/ -- Medtec China 2018 is going to be held 26-28 September in Shanghai. Simultaneously, one of the most attractive conferences to exhibitors and visitors, "MDiT Forum and Regulation Summit 2018," will be co-hosted at the venue. "Regulation, Quality and Technology" are three foci of the conference theme as usual, and the entire content is plann...

TOT BIOPHARM's 16,000L-capacity monoclonal antibodies production base put into operation

Improving the quality of life for cancer patients worldwide with innovative science and technology SUZHOU, China, June 20, 2018 /PRNewswire/ -- Chinese bio-pharmaceutical developer, manufacturer and marketer of oncology drugs TOT BIOPHARM announced recently that its second phase project, a monoclonal antibodies (mAb) production site with 16,000L capacity, was inaugurated in Suzhou Industrial Park...

OASIS Maintains Safety Again at This Year's Canadian Fair

BEIJING, June 20, 2018 /PRNewswire/ -- OASIS International Hospital will once again take its place as this year's Canadian Fair Medical Partner, providing medical assistance and peace of mind throughout the celebrations of Canada's 151st Birthday. Two OASIS First Aid stations will be set up at the event, they can be found both inside and outside the event, with two physicians and nurses available ...

TOT BIOPHARM's 16,000L-capacitymonoclonal antibodies production base put into operation

Improving the quality of life for cancer patients worldwide with innovative science and technology SUZHOU, China, June 20, 2018 /PRNewswire/ -- Chinese bio-pharmaceutical developer, manufacturer and marketer of oncology drugs TOT BIOPHARM announced recently that its second phase project, a monoclonal antibodies (mAb) production site with 16,000L capacity, was inaugurated in Suzhou Industrial Park...

Merck and Alibaba Health Announce Collaboration to Develop Patient-Centric Digital Services in China

SHANGHAI, June 20, 2018 /PRNewswire/ -- Merck, a leading science and technology company, today signed a strategic collaboration agreement with Chinese internet healthcare company Alibaba Health, to provide Chinese patients and their families with improved access to patient-centric healthcare services. At the signing ceremony in Shanghai, both companies announced the collaboration will focus on the...

TUV Rheinland launches first Radiological Health and Safety Convention

MAKATI, Philippines, June 20, 2018 /PRNewswire/ -- TUV Rheinland Philippine will launch the first Radiological Health and Safety Convention on June 27-29, 2018 at the SMX Convention Center, Pasay City, Philippines. Under the backdrop of the overarching theme -- "Building a More Sustainable, Healthier, and Safer Working Environment," all practitioners will have the opportunity for in-dept...

Tuesday 19th June 2018

Luye Pharma Bolsters Its Global Analgesics Portfolio with China Class 1.1 New Compound LY03012 to Start Phase I Clinical Trials

SHANGHAI, June 19, 2018 /PRNewswire/ -- June 19, 2018, Luye Pharma Group announced that clinical applications of the company's new compound candidate, extended release tablets (''LY03012''), a China Class 1.1 new chemical drug, have been formally accepted by the China Food and Drug Administration. LY03012, an investigational drug for analgesia, will now soon commence Phase I clinical trials. ...

Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2018 Financial Results

Earnings Call Scheduled for 8:00 a.m. ET on June 27, 2018 HONG KONG, June 19, 2018 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the fourth quarter and full year fiscal 2018 on Tuesday, June 26, 2018, after the market close.  The Company will host a conference call at 8:00 a.m. ET on Wednesd...

China Biologic Announces Receipt of Non-Binding Acquisition Proposal

BEIJING, June 19, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("CBPO" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that its board of directors (the "Board") has received an unsolicited, preliminary non-binding proposal letter from CCRE Holdings Limited, a wholly owned subs...

Kazia Releases Preliminary Cantrixil Phase I Data

SYDNEY, June 19, 2018 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to provide an interim update to shareholders regarding its phase I clinical trial of Cantrixil (TRX-E-002-1) in relapsed or recurrent ovarian cancer. The phase I study of Cantrixil commenced in December 2016 at five...

Alpha Biopharma Announces Series A Financing

SHANGHAI, June 19, 2018 /PRNewswire/ -- Alpha Biopharma Inc. ("AlphaBio") today announced the first $37M closing of its $65M Series A financing led by Qiming Venture Partners, one of the most prominent venture capital firms in China. Other notable investors that participated in the round included the TF Fund and the LYZZ Healthcare Venture Fund. The proceeds from this financing will be u...

Carmentix announces collaboration for clinical Preterm Birth study

SINGAPORE, June 19, 2018 /PRNewswire/ -- Carmentix Pte. Ltd. is proud to announce a research collaboration with The University of Melbourne (UoM), The Chinese University Hong Kong (CUHK) and The Henan Province People's Hospital for a clinical Preterm Birth study to validate Carmentix's prognostic tool for predicting premature birth. This multi-centre collaboration follows on from the retrospectiv...

Monday 18th June 2018

Hebron Technology Co., Ltd. Exhibited at ACHEMA

WENZHOU, China, June 18, 2018 /PRNewswire/ -- Hebron Technology Co., Ltd. ("Hebron" or the "Company") (Nasdaq: HEBT), a developer, manufacturer and installer of valves and pipe fittings for use in the pharmaceutical, biological, food and beverage, and other clean industries , today announced its participation in the ACHEMA Frankfurt 2018 International Exhibition-Congr...

FrieslandCampina announces publication of milk consumption trends study in SciFed Food and Dairy Technology Journal

SINGAPORE, June 18, 2018 /PRNewswire/ -- FrieslandCampina today announces the publication of a milk consumption trends study in SciFed Food and Dairy Technology Journal. This study is the first of its kind to examine the key drivers and barriers of milk consumption among adult Singaporeans. Led by Dr Kalpana Bhaskaran, Domain Lead for Applied Nutrition & Glycemic I...

Thursday 14th June 2018

Frequently Enjoying Kimchi Decreases Body Fat and Suppresses Obesity-Related Complications

- Animal studies prove that lactic acid bacteria in kimchi reduce body fat and prevent obesity-related complications - This is the result of two separate studies led by Dr. Hak-Jong Choi of the World Institute of Kimchi (WiKim) and Dr. Yang-Hoon Kim of Chungbuk National University in which lactic acid bacteria, isolated from kimchi, were fed to obesity-induced mice SEOUL, South Korea, June 14, ...

Johnson & Johnson Innovation Announces Launch of Shanghai Lung Cancer Innovation QuickFire Challenge

SHANGHAI, June 14, 2018 /PRNewswire/ -- Johnson & Johnson Innovation, Division of Johnson & Johnson (China) Investment Ltd., today announced the launch of the Shanghai Lung Cancer Innovation QuickFire Challenge to identify new solutions for lung health and to combat lung cancer in China and around the world. Avrum Spira, Global Head, Lung Cancer Initiative, Johnson & Johnson,...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks